[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Sanuwave Health Inc (SNWV)

Sanuwave Health Inc (SNWV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 40,200
  • Shares Outstanding, K 8,599
  • Annual Sales, $ 44,050 K
  • Annual Income, $ 11,810 K
  • EBIT $ 2 M
  • EBITDA $ 4 M
  • 60-Month Beta 1.48
  • Price/Sales 0.91
  • Price/Cash Flow 2.75
  • Price/Book 14.38

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.50 +3.89%
on 08/24/26
6.66 -29.80%
on 07/29/26
-1.68 (-26.49%)
since 07/28/26
3-Month
4.50 +3.89%
on 08/24/26
17.00 -72.50%
on 05/29/26
-11.98 (-71.94%)
since 05/28/26
52-Week
4.50 +3.89%
on 08/24/26
42.75 -89.06%
on 08/29/25
-37.76 (-88.98%)
since 08/28/25

Most Recent Stories

More News
Sanuwave Announces Q2 FY2026 Financial Results

Q2 2026 revenues were $9.7 million, down 3% from $10.1 million in Q2 2025.  Q2 2026 gross margin was 76.2%, versus 78.1% in Q2 2025.  GAAP Operating (Loss) Income was $(0.3) million for...

SNWV : 4.68 (+0.32%)
Sanuwave Announces Q2 FY2026 Financial Results

Sanuwave Announces Q2 FY2026 Financial Results ...

SNWV : 4.68 (+0.32%)
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results

EDEN PRAIRIE, Minn., July 30, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will...

SNWV : 4.68 (+0.32%)
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results

Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results...

SNWV : 4.68 (+0.32%)
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance

EDEN PRAIRIE, Minn., July 13, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc.  (the “Company” or “Sanuwave”) (NASDAQ: SNWV), a leading provider of FDA-cleared directed energy systems used in...

SNWV : 4.68 (+0.32%)
Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance

Sanuwave Health Reports Preliminary Q2 2026 Revenue of $9.6–$9.8 Million, Above High End of Revised Guidance...

SNWV : 4.68 (+0.32%)
Sanuwave Health Updates Second Quarter 2026 Guidance

Sanuwave updates guidance for Q2 2026 to $8.5 - $9.5 million Company on pace for record unit sales of applicators in Q2 Market disruption impacting Ultramist system sales EDEN PRAIRIE, Minn.,...

SNWV : 4.68 (+0.32%)
Sanuwave Health Updates Second Quarter 2026 Guidance

Sanuwave Health Updates Second Quarter 2026 Guidance...

SNWV : 4.68 (+0.32%)
Sanuwave Health Q1 Earnings Call Highlights

Sanuwave Health (NASDAQ:SNWV) reported record first-quarter revenue and rising consumables utilization, while management said the advanced wound care market began to recover after a difficult start to...

SNWV : 4.68 (+0.32%)
Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Sanuwave Announces Revenues and Financial Results for Q1 FY2026 ...

SNWV : 4.68 (+0.32%)

Business Summary

SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in...

See More

Key Turning Points

3rd Resistance Point 4.80
2nd Resistance Point 4.75
1st Resistance Point 4.71
Last Price 4.68
1st Support Level 4.62
2nd Support Level 4.57
3rd Support Level 4.53

See More

52-Week High 42.75
Fibonacci 61.8% 28.14
Fibonacci 50% 23.63
Fibonacci 38.2% 19.11
Last Price 4.68
52-Week Low 4.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.